tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Oruka Therapeutics data hits ‘bull case’ scenario, says Clear Street
PremiumThe FlyOruka Therapeutics data hits ‘bull case’ scenario, says Clear Street
13d ago
Oruka Therapeutics sells 10.9M shares at $15 in private placement
Premium
The Fly
Oruka Therapeutics sells 10.9M shares at $15 in private placement
13d ago
Oruka Therapeutics announces interim data from ORKA-001 trial at EADV
Premium
The Fly
Oruka Therapeutics announces interim data from ORKA-001 trial at EADV
13d ago
Oruka Therapeutics: Promising Clinical Developments and Strong Financial Position Justify Buy Rating
PremiumRatingsOruka Therapeutics: Promising Clinical Developments and Strong Financial Position Justify Buy Rating
2M ago
Oruka Therapeutics reports Q2 EPS (46c), consensus (43c)
Premium
The Fly
Oruka Therapeutics reports Q2 EPS (46c), consensus (43c)
2M ago
Oruka Therapeutics: Promising Pipeline and Strategic Advancements Drive Buy Rating
Premium
Ratings
Oruka Therapeutics: Promising Pipeline and Strategic Advancements Drive Buy Rating
2M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100